Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
68.98 USD | -1.05% |
|
+5.18% | +122.59% |
06-21 | Evercore ISI Boosts Price Target on Insmed to $75 From $42, Maintains Outperform Rating | MT |
06-20 | JPMorgan Raises Insmed's Price Target to $72 From $55, Maintains Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+122.59% | 11.12B | |
+16.49% | 122B | |
+21.73% | 115B | |
+22.18% | 26.64B | |
-21.81% | 19.91B | |
-16.89% | 16.32B | |
-18.81% | 15.49B | |
-44.74% | 15.52B | |
+62.72% | 14.83B | |
+3.09% | 13.67B |
- Stock Market
- Equities
- INSM Stock
- News Insmed Incorporated
- Insmed Insider Sold Shares Worth $6,316,579, According to a Recent SEC Filing